Introduction: Interleukin-13 receptor alpha2 (IL13Ra2) has been reported to be associated with invasion and metastasis of digestive cancers including colorectal cancer and pancreatic cancer. However, little is known about its role on hepatocellular carcinoma (HCC). This study aims to investigate the effect of IL13Ra2 on the progression of HCC. Methods: Expression of IL13Ra2 was measured on 81 Human liver tissue samples, which were collected from patients received hepatectomy, by immunohistochemistry and on 14 HCC cell lines by western blot. Independents factors, overall survival (OS) and recurrence-free survival (RFS) of patients were compared between high-IL13Ra2 expression group and low-IL13Ra2 group.HepG2 and SMMC7721 HCC cell lines were selected to knock down IL13Ra2 expression by PLKO-Tet-On lentivirus. Cell Counting Kit-8 (CCK-8) assays and colony formation assays were performed on selected cell lines. HepG2-vector and HepG2-sh IL13Ra2 cells were used to perform in vivo tumorigenicity assay. Results: IL13Ra2 showed higher expression in adjacenttumor tissues than tumor tissues (P< 0.001). Differentiation of HCC was the only independent factor associated with IL13Ra2 expression in tumor tissues (HR: 0.19, 95% CI: 0.067-0.538, P =0.002). No significant difference of OS and RFS were found between high-IL13Ra2 expression group and low-IL13Ra2 group. Knockdown of IL13Ra2 promoted growth of HepG2 and SMMC7721 cells. Subcutaneous tumors from HepG2-sh IL13Ra2 cells showed larger in volume and heavier in weight (P< 0.05), in comparison to their empty control. Conclusion: Our research clarified that reduced expression of IL13Ra2 promoted growth of hepatocellular carcinoma.
EP01B-080 THE EFFECT OF ANTIVIRAL TREATMENT FOR HEPATITIS B VIRUS -RELATED HEPATOCELLULAR CARCINOMA PATIENTS AFTER CURATIVE LIVER RESECTION WAS IMPAIRED BY ELEVATED LACTATE J. Zhao 1 and W. Zhang 2 1 Hepatic Surgery Center, and 2 Hepatic Surgical Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China Background: Nucleoside and nucleotide analogues (NAs) has a risk of mitochondrial toxicity and therefore induces rising of lactate. We aim to evaluate the impact of lactate on the NAs therapy in hepatitis B virus (HBV)-related hepatocellular cancer (HCC) patients after curative liver resection. Methods: 557 HBV -related HCC patients were enrolled and divided into treatment and control group according to whether they received NAs therapy or not. Perioperative and prognosis data were retrospectively reviewed. Results: Patients in treatment group had a better overall survival rate (OS) than those in control group (p = 0.036). There was no significant difference of recurrence -free survival rate (RFS) between the two groups (p = 0.178). NAs therapy could benefit the OS for early stage HCC patients (p = 0.028), and for advanced stage HCC patients only after the level of lactate was adjusted (p < 0.05). Patients with advanced stage HCC in treatment group had a higher value of lactate than those in control group (p = 0.001). Besides, patients with advanced stage HCC had a higher value of lactate than patients with early stage HCC in both groups (p < 0.05). Conclusions: NAs would benefit the long -term outcomes of early stage HBV -related HCC patients after curative liver resection. However, the long -term outcomes improvement effect of NAs therapy is counteracted by the adverse effect of elevated lactate for patients with advanced stage HBV -related HCC after curative liver resection. There is no consensus on the safe resection margin in patients with hepatocellular carcinoma (HCC). We investigated the change of tumor microenvironment according to the resection margin. Methods: We prospectively collected the specimen of 60 patients with HCC. We selected three portions of specimens as follows: tumor, 1cm and 2cm margin normal tissue. We investigated the expression status of tumor microenvironment genes. We compared the expression status according to recurrence, HCC gross type and positron emission tomography (PET) positivity. We divided the patients into two groups as follows: group 1 included expanding and vaguely nodular types whereas group 2 included nodular with perinodular extension, multinodular confluent and infiltrative types. Results: Group 2 had a higher prevalence of PET positive [6 (37.5%) vs 10 (62.5%)] and recurrence [5 (16.7%) vs 17 (56.7%)]. However, in cases with more than 1cm resection margin, there was no difference of recurrence rate [9 (75%), p=0.017 vs 8 (44.4%), p=0.06]. Beta-catenin was significantly decreased and E-cadherin was significantly increased according to the resection margin in group 1. Group 2 and PET positive patients did not show any significant change of beta-catenin and E-cadherin until 2cm resection margin. Conclusions: Our data suggest that patients with HCC of expanding and vaguely nodular gross types may safely undergo surgical resection with a narrow resection margin and patients with HCC of nodular with perinodular extension, multinodular confluent and infiltrative gross type must undergo surgical resection with more than 2cm resection margin because of tumor microenvironment condition.
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